乳がんのネオアジュバント化学療法を受けている患者の予後バイオマーカーとしての周辺血液パラメータの臨床的意義
Tae-In Yoon1, Seunghee Baek2, Ji Hyeon Lee3
1Division of Breast Surgery, Department of Surgery, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
BMC cancer
|January 4, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.4K
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
18.2K
